Search clinical trials for: anti-IL17 biologic agents

Total 195299 results

Seoul National University Hospital
Chonbuk National University Hospital; Chonnam National University Hospital; Korea... and other collaborators

Terminated

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

Rheumatoid Arthritis | Chronic Hepatitis B | Juvenile Idiopathic Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis

Korea, Republic of
Human Genome Sciences Inc., a GSK Company
GlaxoSmithKline

Completed

Belimumab in Remission of VASculitis (BREVAS)

Vasculitis

United States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
West China Hospital
First Affiliated Hospital of Chongqing Medical University; Sichuan Cancer Hospital... and other collaborators

Recruiting

Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer

Rectal Cancer | Radiotherapy | Anti-PD-1 Antibody | MSI-H | Mmr Deficiency

China
Colgate Palmolive

Recruiting

Anti-gingivitis Mouthrinse

Gingivitis

Germany
Société Française d'Endoscopie Digestive

Not yet recruiting

Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG) (ANTIMIG)

GastroEsophageal Cancer | Stent Migration

France
Rennes University Hospital

Completed

Evaluation of the Effect of Dextran Sulphate on Anti-Xa Activities Measured (DEXHEP)

Unfractionated Heparin Treatment

France
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies

HIV Infections | Pregnancy

United States
Sandoz

Completed

To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets

Allergy
Hubei Biological Medicine Industrial Technology...
Academy Military Medical Science, China

Completed

Tolerability, Safety and Pharmacokinetic Study Of Methosulide in Healthy Adult Subjects

Healthy

China
Tang-Du Hospital

Recruiting

Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC

NSCLC Stage IV | Oligometastasis

China
Sanofi

Active, not recruiting

A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma

Plasma Cell Myeloma

Italy, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
Sanofi

Completed

Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation

Plasma Cell Myeloma

France, Germany, Italy, Spain
Sanofi

Terminated

Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Immune System Disorder

United States, Spain
The Lymphoma Academic Research Organisation

Completed

Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

Hodgkin Lymphoma | Coexisting Medical Conditions

France, Belgium
Sanofi

Terminated

Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies

Prostate Cancer | Non-small Cell Lung Cancer

Taiwan, United States, France, Italy, United Kingdom
Sanofi

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma

Plasma Cell Myeloma

United States, Czechia, France
Claudio Gobbi
Merck AG Switzerland

Active, not recruiting

Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy

Multiple Sclerosis

Switzerland
Mahidol University
Ministry of Health, Thailand

Unknown

Treatment of Adult-Onset Immunodeficiency With Bortezomib

Adult-onset Immunodeficiency

Thailand
Hoffmann-La Roche
Trimeris

Completed

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

HIV Infections

United States
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer

Non-small-cell Lung Cancer

Greece
Precirix

Terminated

A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer

Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment

United States, Canada
Università degli Studi dell'Insubria

Unknown

Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan

Diastolic Function | Left Atrial Volume | Renin Angiotensin System | Hypertensive Heart Disease | Antihypertensive Drugs

Italy
NovelMed Therapeutics

Not yet recruiting

Study of NM8074 in Patients With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection

Hepatocellular Carcinoma | Graft Rejection | Immunotherapy | Immune Checkpoint Inhibitor

China
Hospices Civils de Lyon

Unknown

Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis (NMDARE-HSE)

Autoimmune Encephalitis | Anti NMDA Receptor Encephalitis | Herpetic Encephalitis

France
CStone Pharmaceuticals

Completed

A Study of CS1002 in Subjects With Advanced Solid Tumors

Solid Tumor, Adult

Hong Kong, Australia
Johannes Gutenberg University Mainz

Completed

Influence of Perioperative Fluid Balance on Serum Concentrations of Antibiotics and Surgical Site Infections

Surgical Wound Infection | Anti-Bacterial Agents | Antibiotic

Germany
Shanghai Huaota Biopharmaceutical Co., Ltd.

Recruiting

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

NSCLC | Advanced Solid Tumor

United States, China
The First Affiliated Hospital of Soochow University

Recruiting

Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT

Safety and Efficacy

China
University Hospital, Toulouse

Completed

A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis (TNF-RS-PR)

Rheumatoid Arthritis

France
Derming SRL

Completed

Clinical Trial on a Topical "Antiage" Face Gel (E2912)

Wrinkles

Italy
Revision Skincare
KGL, Inc.

Completed

A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum

Wrinkle | Photoaging

United States
EffePharm LTD
ProRelix Services LLP

Completed

Evaluate the Efficacy and Safety of Uthever NMN(Nicotinamide Mononucleotide, a Form of Vitamin B3) (NMN)

Aging

India
Kwang Dong Pharmaceutical co., ltd.

Completed

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Drug Toxicity

Korea, Republic of
Makerere University
Northwestern University

Completed

Antiretroviral Drug Levels During and After Pregnancy

Pharmacokinetics

Uganda
Sanofi

Terminated

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder (GEMINI)

Anxiety Disorders

Romania, Slovakia, Croatia, Austria, Finland
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs

HIV Infection | Healthy

United States
Radboud University Medical Center

Unknown

Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Netherlands
Parc de Salut Mar

Completed

Generation of Biological Samples Positive to Hydromorphone for Anti-doping Control (HM)

Healthy Volunteers

Spain
Processa Pharmaceuticals

Terminated

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

United States
Washington University School of Medicine
Mallinckrodt

Completed

Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass

Congenital Heart Disease

United States
Tang-Du Hospital

Not yet recruiting

Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

Non-Small Cell Lung Cancer | Anti Angiogenesis

China
Shanghai Jiao Tong University School of Medicine

Recruiting

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Chemotherapy | Oral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant Therapy

China
University of British Columbia

Terminated

A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma (ADAM)

Anti-Xa Activity

Canada
Shanghai Zhongshan Hospital

Recruiting

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC

Hepatocellular Carcinoma

China
Lawson Health Research Institute
Academic Medical Organization of Southwestern Ontario

Completed

Evaluation of Heparin Rebound in Cardiac Surgery

Coagulation Delay

Canada
Massachusetts General Hospital

Terminated

Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing (MAINTANCAVAS)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

United States
Akeso
Akeso Pharmaceuticals, Inc.

Terminated

A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma

China
Jason J. Luke, MD
Bristol-Myers Squibb

Recruiting

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors

Melanoma | Carcinoma, Renal Cell | Unresectable Solid Tumors

United States
Chinese PLA General Hospital

Unknown

Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors

Solid Tumor

China

Search clinical trials for: anti-IL17 biologic agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations